AI
System which identifies patients at risk of fatal heart attack obtains CE mark.
Companies will shed light on immunotherapy, an emerging therapeutic approach that helps the immune system fight cancer, in a brand-new study on one of the most impacting cancers worldwide.
The system uses heatmaps to make AI decisions transparent to clinicians.
Also: PainChek's app picks up European and Australian regulatory clearances; Digital health access as a social determinant of health.
This Series C comes less than a year after the startup closed its $200 million Series B in 2020.
The company's technology looks to reduce the burden on pathologists reviewing digital slides, while also serving as a safety net to reduce errors.
Along with the support of a Google Cloud-backed data platform, the partners will work to build and validate digital health programs for early intervention and engagement.
Also: The Consumer Technology Association releases industry standards focused on health AI trust; new updates in the home COVID-19 testing market.
The solution uses AI and machine learning to improve adherence.
Saykara's founder and team will be augmenting Nuance's R&D division.